BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33920268)

  • 1. USP22 Suppresses
    Kosinsky RL; Saul D; Ammer-Herrmenau C; Faubion WA; Neesse A; Johnsen SA
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity.
    Kosinsky RL; Zerche M; Saul D; Wang X; Wohn L; Wegwitz F; Begus-Nahrmann Y; Johnsen SA
    Cell Death Differ; 2020 Apr; 27(4):1328-1340. PubMed ID: 31527800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer.
    Kosinsky RL; Helms M; Zerche M; Wohn L; Dyas A; Prokakis E; Kazerouni ZB; Bedi U; Wegwitz F; Johnsen SA
    Cell Death Dis; 2019 Dec; 10(12):911. PubMed ID: 31801945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
    Liu YL; Yang YM; Xu H; Dong XS
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
    Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
    Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usp22 deficiency impairs intestinal epithelial lineage specification in vivo.
    Kosinsky RL; Wegwitz F; Hellbach N; Dobbelstein M; Mansouri A; Vogel T; Begus-Nahrmann Y; Johnsen SA
    Oncotarget; 2015 Nov; 6(35):37906-18. PubMed ID: 26431380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted protein acidic and rich in cysteine functions in colitis via IL17A regulation in mucosal CD4
    Tanaka M; Takagi T; Naito Y; Uchiyama K; Hotta Y; Toyokawa Y; Ushiroda C; Hirai Y; Aoi W; Higashimura Y; Mizushima K; Okayama T; Katada K; Kamada K; Ishikawa T; Handa O; Itoh Y
    J Gastroenterol Hepatol; 2018 Mar; 33(3):671-680. PubMed ID: 28582593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway.
    Liu YL; Jiang SX; Yang YM; Xu H; Liu JL; Wang XS
    Cell Biochem Biophys; 2012 Jan; 62(1):229-35. PubMed ID: 21928107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced
    Jeusset LM; Guppy BJ; Lichtensztejn Z; McDonald D; McManus KJ
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells.
    Schneider D; Chua RL; Molitor N; Hamdan FH; Rettenmeier EM; Prokakis E; Mishra VK; Kari V; Wegwitz F; Johnsen SA; Kosinsky RL
    Clin Epigenetics; 2019 Jul; 11(1):98. PubMed ID: 31266541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes.
    Hases L; Indukuri R; Birgersson M; Nguyen-Vu T; Lozano R; Saxena A; Hartman J; Frasor J; Gustafsson JÅ; Katajisto P; Archer A; Williams C
    Cancer Lett; 2020 Nov; 492():54-62. PubMed ID: 32711097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer.
    Liu YL; Yang YM; Xu H; Dong XS
    J Surg Oncol; 2011 Mar; 103(3):283-9. PubMed ID: 21337558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Protective Role of
    Lee YK; Mehrabian P; Boyajian S; Wu WL; Selicha J; Vonderfecht S; Mazmanian SK
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30429227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
    Xu H; Li J; Chen H; Ghishan FK
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin Specific Peptidase 22 Regulates Histone H2B Mono-Ubiquitination and Exhibits Both Oncogenic and Tumor Suppressor Roles in Cancer.
    Jeusset LM; McManus KJ
    Cancers (Basel); 2017 Dec; 9(12):. PubMed ID: 29210986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
    Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
    Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-specific peptide 22 acts as an oncogene in gastric cancer in a son of sevenless 1-dependent manner.
    Lim C; Xu JC; Chen TY; Xu JX; Chen WF; Hu JW; Li QL; Zhang YQ
    Cancer Cell Int; 2020; 20():45. PubMed ID: 32063746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.